Skip to content
CL23

Drawing based on the label description. No photo yet.

“Fenofibrate capsules, USP (micronized) 134 mg are opaque white cap and opaque yellow body, hard gelatin capsules, printed in black ink "CL" and "23" on opposing cap and body portions of the capsule”

CL 23 pill

Pill with imprint CL 23 is white & yellow, capsule, 19 mm and has been identified as Fenofibrate 134 mg. It is used for high cholesterol, high triglycerides and heart disease. It is supplied by Bostal LLC.

Fenofibrate 134 mg

Imprint
CL 23
Strength
134 mg
Used for
High cholesterol, high triglycerides and heart disease
Color
White, Yellow
Shape
Capsule / oblong
Size
19 mm
Score
No score line
Form
Capsule
Manufacturer
Bostal LLC
Drug class
Peroxisome proliferator-activated receptor alpha agonist
NDC
35561-346, 35561-346-11, 35561-346-12, 35561-346-13

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Fenofibrate pills and guides

What is Fenofibrate used for?

Fenofibrate is used for high cholesterol, high triglycerides and heart disease.

Medicine type
Peroxisome proliferator-activated receptor alpha agonist
Official uses from the US prescribing label

Primary Hypercholesterolemia or Mixed Dyslipidemia

Fenofibrate tablets are indicated as adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol (Total-C), Triglycerides and apolipoprotein B (Apo B), and to increase high-density lipoprotein cholesterol (HDL-C) in adult patients with primary hypercholesterolemia or mixed dyslipidemia.

Severe Hypertriglyceridemia

Fenofibrate tablets are also indicated as adjunctive therapy to diet for treatment of adult patients with severe hypertriglyceridemia. Improving glycemic control in diabetic patients showing fasting chylomicronemia will usually obviate the need for pharmacologic intervention.

Markedly elevated levels of serum triglycerides (e.g. > 2,000 mg/dL) may increase the risk of developing pancreatitis. The effect of fenofibrate therapy on reducing this risk has not been adequately studied.

Important Limitations of Use

Fenofibrate at a dose equivalent to 160 mg of fenofibrate tablet was not shown to reduce coronary heart disease morbidity and mortality in a large, randomized controlled trial of patients with type 2 diabetes mellitus.

From the FDA-approved label on DailyMed (published Oct 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows CL 23. The parts can be split between the two sides, so turn the pill over and check both.
  • It is white & yellow, capsule, 19 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Fenofibrate

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Fenofibrate pills